| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Alzamend Neuro, Inc. (ALZN) has 3 insiders with recent SEC Form 4 filings, including 12 buys and 1 sell. ALZN is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 25 | $30.50 | - | |
| Dir | 0 | - | - | |
| Dir | 0 | - | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 31, 2021 | Ault Milton C III | 10% Owner | Buy | 8,000 | $1.91 | $15,289.60 | +0.1% | -35.3% | -70.3% | |
| Dec 23, 2021 | Ault Milton C III | 10% Owner | Buy | 1,612 | $2.10 | $3,377.30 | - | -37.2% | -69.8% | |
| Dec 20, 2021 | Ault Milton C III | 10% Owner | Buy | 38,000 | $2.24 | $84,968.70 | +0.3% | -47.1% | -61.1% | |
| Dec 14, 2021 | Gustafson Mark | Director | Sell | 20,000 | $2.85 | $57,086.00 | -40.0% | -69.1% | -69.8% | |
| Dec 1, 2021 | Ault Milton C III | 10% Owner | Buy | 22,319 | $2.05 | $45,782.24 | +0.2% | -36.4% | -40.5% | |
| Nov 23, 2021 | Ault Milton C III | 10% Owner | Buy | 19,681 | $1.92 | $37,813.69 | +0.1% | -45.0% | -44.5% | |
| Nov 8, 2021 | Ault Milton C III | 10% Owner | Buy | 145,000 | $2.57 | $373,114.00 | +2.2% | -45.2% | -58.6% | |
| Sep 14, 2021 | Ault Milton C III | 10% Owner | Buy | 5,000 | $2.70 | $13,492.00 | - | -9.8% | -57.1% | |
| Aug 27, 2021 | Ault Milton C III | 10% Owner | Buy | 6,000 | $2.91 | $17,430.00 | - | -21.5% | -67.7% | |
| Aug 17, 2021 | Ault Milton C III | 10% Owner | Buy | 4,000 | $3.29 | $13,170.00 | - | -30.6% | -64.2% |